Parkinson disease, the effect of levodopa, and t... [Arch Neurol. 1999] - PubMed

loading

Review [Parkinson disease]. [Praxis (Bern 1994). 2001]
Review [Parkinson disease].
Moore AP, Clarke CE. Praxis (Bern 1994). 2001 Jun 7; 90(23):1041-6.
Review [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease]. [Ideggyogy Sz. 2007]
Review [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
Klivényi P, Vécsei L. Ideggyogy Sz. 2007 Jan 20; 60(1-2):61-4.
Suicide following duodenal levodopa infusion for Parkinson's disease. [Mov Disord. 2009]
Suicide following duodenal levodopa infusion for Parkinson's disease.
Santos-García D, Macías M, Llaneza M, Aneiros A. Mov Disord. 2009 Oct 15; 24(13):2029-30.
Review Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems. [J Neural Transm. 2002]
Review Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems.
Carlsson A. J Neural Transm. 2002 May; 109(5-6):777-87.
Review Imaging the dopamine system to assess disease-modifying drugs: studies comparing dopamine agonists and levodopa. [Neurology. 2003]
Review Imaging the dopamine system to assess disease-modifying drugs: studies comparing dopamine agonists and levodopa.
Marek K, Jennings D, Seibyl J. Neurology. 2003 Sep 23; 61(6 Suppl 3):S43-8.

Medical management of Parkinson's disease: focus on neuroprotection. [Curr Neuropharmacol. 2011]
Medical management of Parkinson's disease: focus on neuroprotection.
Boll MC, Alcaraz-Zubeldia M, Rios C. Curr Neuropharmacol. 2011 Jun; 9(2):350-9.
Review Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training. [Parkinsonism Relat Disord. 2008]
Review Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training.
Ciucci MR, Ma ST, Kane JR, Ahrens AM, Schallert T. Parkinsonism Relat Disord. 2008; 14 Suppl 2:S172-5. Epub 2008 Jun 27.
Mood fluctuations in Parkinson's disease: a pilot study comparing the effects of intravenous and oral levodopa administration. [Neuropsychiatr Dis Treat. 2005]
Mood fluctuations in Parkinson's disease: a pilot study comparing the effects of intravenous and oral levodopa administration.
Richard IH, Frank S, LaDonna KA, Wang H, McDermott MP, Kurlan R. Neuropsychiatr Dis Treat. 2005 Sep; 1(3):261-8.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Lat...
Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA.
Arch Neurol. 1999 May ;56(5):529-35.

PubMed
Founding of a German society of Visceral Surgery.
Founding of a German society of Visceral Surgery.
Langenbecks Arch Surg. 1999 Apr ;384(2):131-2.

PubMed
Anthrax as a biological weapon: medical and public health management. Working Gr...
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
JAMA. 1999 May 12 ;281(18):1735-45.

PubMed
Depressed adolescents grown up.
Depressed adolescents grown up.
JAMA. 1999 May 12 ;281(18):1707-13.

PubMed
Prospective analysis of the relation between DSM-III anxiety disorders and alcoh...
Prospective analysis of the relation between DSM-III anxiety disorders and alcohol use disorders.
Am J Psychiatry. 1999 May ;156(5):723-32.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed